AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases

AKR1D1 and CYP7B1 mutations in patients with inborn errors of bile acid metabolism: Possibly underdiagnosed diseases

Background: Inborn errors of bile acid metabolism (IEBAM) cause rare but treatable genetic disorders that can present as neonatal cholestasis or neurological diseases. Without timely primary bile acid treatment, patients may develop liver failure early in life. This study aimed to analyze the types...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Ju-Yin Chen, Jia-Feng Wu, Akihiko Kimura, Hiroshi Nittono, Bang-Yu Liou, Chee-Seng Lee, Ho-Sheng Chen, Yu-Chun Chiu, Yen-Hsuan Ni, Steven Shinn-Forng Peng, Wang-Tso Lee, I-Jung Tsai, Mei-Hwei Chang, Huey-Ling Chen
Natura:	Articolo
Lingua:	English
Pubblicazione:	Elsevier 2020-02-01
Serie:	Pediatrics and Neonatology
Accesso online:	http://www.sciencedirect.com/science/article/pii/S1875957219300956

Documenti analoghi

Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.
di: Lee, W, et al.
Pubblicazione: (2009)

Structure-activity relationships of human AKR-type oxidoreductases involved in bile acid synthesis: AKR1D1 and AKR1C4.
di: Lee, W, et al.
Pubblicazione: (2009)

Navigating cholestasis: identifying inborn errors of bile acid metabolism for precision diagnosis
di: Hiroshi Nittono, et al.
Pubblicazione: (2024-04-01)

Enzymes of the AKR1B and AKR1C subfamilies and uterine diseases
di: Tea eLanisnik Rizner
Pubblicazione: (2012-03-01)

Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis
di: Chee-Seng Lee, et al.
Pubblicazione: (2017-03-01)

Clinical and genetic features of congenital bile acid synthesis defect with a novel mutation in AKR1D1 gene sequencing
di: Anh-Hoa Nguyen Pham, MD, PhD, et al.
Pubblicazione: (2022-06-01)

Expression of the Aldo-Keto Reductases AKR1B1 and AKR1B10 in Human Cancers.
di: Brian eLaffin, et al.
Pubblicazione: (2012-06-01)

Roles of AKR1C3 in malignancy
di: Xin-Zhu Xiao, et al.
Pubblicazione: (2021-05-01)

Human and murine steroid 5β-reductases (AKR1D1 and AKR1D4): Insights into the role of the catalytic glutamic acid
di: Chen, M, et al.
Pubblicazione: (2019)

INCREASED EXPRESSION OF AKR1C2 AND AKR1B1 GENES IS ASSOCIATED WITH THE DEVELOPMENT OF RESISTANCE TO DOCETAXEL IN PROSTATE CANCER
di: Pudova Е.A.
Pubblicazione: (2023-11-01)

In-silico Investigations of quinine and quinidine as potential Inhibitors of AKR1B1 and AKR1B10: Functional and structural characterization.
di: Syeda Abida Ejaz, et al.
Pubblicazione: (2022-01-01)

Ruthenium complexes show potent inhibition of AKR1C1, AKR1C2, and AKR1C3 enzymes and anti-proliferative action against chemoresistant ovarian cancer cell line
di: Jakob Kljun, et al.
Pubblicazione: (2022-08-01)

Expression of progesterone metabolizing enzyme genes (AKR1C1, AKR1C2, AKR1C3, SRD5A1, SRD5A2) is altered in human breast carcinoma
di: Wiebe John P, et al.
Pubblicazione: (2004-06-01)

Modeling single nucleotide polymorphisms in the human AKR1C1 and AKR1C2 genes: implications for functional and genotyping analyses.
di: Jonathan W Arthur, et al.
Pubblicazione: (2010-12-01)

Unravelling the role of AKR1D1 in human hepatocytes
di: Nikolaou, N
Pubblicazione: (2017)

Bile acid homeostasis in female mice deficient in Cyp7a1 and Cyp27a1
di: Daniel Rizzolo, et al.
Pubblicazione: (2021-12-01)

AKR1C1 interacts with STAT3 to increase intracellular glutathione and confers resistance to oxaliplatin in colorectal cancer
di: Zhiwen Fu, et al.
Pubblicazione: (2024-12-01)

The Role of AKR1B10 in Physiology and Pathophysiology
di: Satoshi Endo, et al.
Pubblicazione: (2021-05-01)

Pleiotropic Actions of Aldehyde Reductase (AKR1A)
di: Junichi Fujii, et al.
Pubblicazione: (2021-05-01)

Cholestasis associated to inborn errors in bile acid synthesis
di: Elisa Herraez, et al.
Pubblicazione: (2022-12-01)

Expression of AKR1C3 Protein in Human Keloid Skin Tissue
di: Doo Hyun Nam, et al.
Pubblicazione: (2016-02-01)

Avasimibe Dampens Cholangiocarcinoma Progression by Inhibiting FoxM1-AKR1C1 Signaling
di: Yunshu Gao, et al.
Pubblicazione: (2021-05-01)

AKR1C3 in carcinomas: from multifaceted roles to therapeutic strategies
di: Mengnan Li, et al.
Pubblicazione: (2024-03-01)

Natural Product Alantolactone Targeting AKR1C1 Suppresses Cell Proliferation and Metastasis in Non-Small-Cell Lung Cancer
di: Zhiwen Fu, et al.
Pubblicazione: (2022-03-01)

AKR1B1-Induced Epithelial–Mesenchymal Transition Mediated by RAGE-Oxidative Stress in Diabetic Cataract Lens
di: Tsung-Tien Wu, et al.
Pubblicazione: (2020-03-01)

Association of CYP1A1 and CYP1B1 Gene Polymorphisms with TypeⅠEndometrial Cancer in Chinese Women
di: HUANG Yu, et al.
Pubblicazione: (2018-01-01)

Glucocorticoids regulate AKR1D1 activity in human liver in vitro and in vivo
di: Nikolaou, N, et al.
Pubblicazione: (2020)

High expression of AKR1C1 is associated with proliferation and migration of small-cell lung cancer cells
di: Tian H, et al.
Pubblicazione: (2016-05-01)

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition
di: Yu Meng, et al.
Pubblicazione: (2023-12-01)

Overexpression of AKR1B10 Predicts Poor Prognosis in Gastric Cancer Patients Undergoing Surgical Resection
di: Yu-Yin Liu, et al.
Pubblicazione: (2022-12-01)

AKR1B10 and digestive tumors development: a review
di: Yao Shen, et al.
Pubblicazione: (2024-12-01)

Analogues of Natural Chalcones as Efficient Inhibitors of AKR1C3
di: Gabriele Möller, et al.
Pubblicazione: (2022-01-01)

A novel AKR1C3 specific prodrug AST-3424 and its combination therapy in hepatocellular carcinoma
di: Chen Xun, et al.
Pubblicazione: (2023-06-01)

Long read sequencing characterises a novel structural variant, revealing underactive AKR1C1 with overactive AKR1C2 as a possible cause of severe chronic fatigue
di: Julia Oakley, et al.
Pubblicazione: (2023-11-01)

ZNF521/EBF1 axis regulates AKR1B1 to promote the proliferation, migration, and invasion of gastric cancer cells
di: Yu Cheng, et al.
Pubblicazione: (2023-03-01)

AKR1D1 knockout mice develop a sex-dependent metabolic phenotype
di: Gathercole, LL, et al.
Pubblicazione: (2022)

Relationship of the AKR1B1 rs759853 and rs9640883 with the development of diabetic retinopathy
di: S.Iu. Mogilevskyy, et al.
Pubblicazione: (2017-04-01)

Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degrader
di: Angelica V. Carmona, et al.
Pubblicazione: (2024-04-01)

Liquiritin, as a Natural Inhibitor of AKR1C1, Could Interfere With the Progesterone Metabolism
di: Chenming Zeng, et al.
Pubblicazione: (2019-07-01)

Transient elastography correlated with diffusion-weighted magnetic resonance imaging and cholestatic complications
di: Chai-Zhaou Lee, et al.
Pubblicazione: (2019-11-01)